{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:31:58Z","timestamp":1792816318898,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.thromres.2026.109771","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T21:52:58Z","timestamp":1782683578000},"page":"109771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pre-analytical storage and reagent-dependent sensitivity as sources of variability in prothrombin time and activated partial thromboplastin time measurements"],"prefix":"10.1016","volume":"263","author":[{"given":"A.D.","family":"van Dam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Bioch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.H.","family":"Jeninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"de Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Rijpma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.M.","family":"Thelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.M.C.","family":"Henskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.G.M.","family":"van Oerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Stroobants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.thromres.2026.109771_bb0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/ijlh.12318","article-title":"Stability of coagulation proteins in lyophilized plasma","volume":"37","author":"Jennings","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2026.109771_bb0010","first-page":"233","article-title":"Impact of water temperature on reconstitution of quality controls for routine hemostasis testing","volume":"8","author":"De Nitto","year":"2021","journal-title":"Diagnosis (Berlin, Germany)."},{"issue":"12","key":"10.1016\/j.thromres.2026.109771_bb0015","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1016\/S2352-3026(24)00281-3","article-title":"Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants","volume":"11","author":"Ageno","year":"2024","journal-title":"Lancet Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2026.109771_bb0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/ijlh.12640","article-title":"Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme","volume":"39","author":"Van Blerk","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109771_bb0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1160\/TH14-02-0161","article-title":"Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey","volume":"113","author":"Van Blerk","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2026.109771_bb0030","first-page":"306","article-title":"The effect of oral direct inhibitors on routine haemostasis screening assays","volume":"10","author":"Agar","year":"2013","journal-title":"Ned Tijdschr Hematol"},{"key":"10.1016\/j.thromres.2026.109771_bb0035","series-title":"Richtlijn Antitrombotisch beleid 2025","author":"NIV","year":"2016"},{"issue":"5","key":"10.1016\/j.thromres.2026.109771_bb0040","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jtha.2025.12.030","article-title":"A 25-year evaluation of direct local international normalized ratio calibration of the Owren type prothrombin time method in Sweden","volume":"24","author":"Hillarp","year":"2026","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109771_bb0045","first-page":"87","article-title":"A sensitivity comparison of the Quick and Owren Prothrombin Time methods in oral anticoagulant therapy","volume":"1","author":"Horsti","year":"2009","journal-title":"Hematol. Rev."},{"key":"10.1016\/j.thromres.2026.109771_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120745","article-title":"Evaluation of the commutability of lombardy region EQA control materials for enzymes, calcium, and creatinine","volume":"580","author":"Carobene","year":"2026","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"1","key":"10.1016\/j.thromres.2026.109771_bb0055","article-title":"Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.thromres.2026.109771_bb0060","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0032-1319768","article-title":"Quality standards for sample processing, transportation, and storage in hemostasis testing","volume":"38","author":"Adcock Funk","year":"2012","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109771_bb0065","series-title":"H21, Collection, Transport, and Processing of Blood Specimens for Testing Plasma-based Coagulation Assays; Approved Guideline \u2013 Sixth Edition","author":"CLSI","year":"2024"},{"issue":"5","key":"10.1016\/j.thromres.2026.109771_bb0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2131\/jts.28.439","article-title":"Mechanism for shortening PT and APTT in dogs and rats\u2014effect of fibrinogen on PT and APTT","volume":"28","author":"Kurata","year":"2003","journal-title":"J. Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2026.109771_bb0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.thromres.2008.11.010","article-title":"Effect of freezing method and storage at \u221220 degrees C and \u221270 degrees C on prothrombin time, aPTT and plasma fibrinogen levels","volume":"124","author":"Alesci","year":"2009","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2026.109771_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00001721-200106000-00002","article-title":"Stability of coagulation proteins in frozen plasma","volume":"12","author":"Woodhams","year":"2001","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"2","key":"10.1016\/j.thromres.2026.109771_bb0085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1160\/TH07-07-0448","article-title":"Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature","volume":"99","author":"Z\u00fcrcher","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109771_bb0090","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1365-2516.1998.440646.x","article-title":"Influence of phospholipids on the assessment of factor VIII activity","volume":"4","author":"Mikaelsson","year":"1998","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.thromres.2026.109771_bb0095","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2141.1999.01596.x","article-title":"Lipid composition of seven APTT reagents in relation to heparin sensitivity","volume":"106","author":"Kitchen","year":"1999","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2026.109771_bb0100","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1538-7836.2006.01848.x","article-title":"Phospholipid composition controls thromboplastin sensitivity to individual clotting factors","volume":"4","author":"Smith","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2026.109771_bb0105","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1538-7836.2012.04906.x","article-title":"APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent","volume":"10","author":"Kumano","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109771_bb0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/ijlh.14549","article-title":"Laboratory identification of lupus anticoagulant (LA) using different activated partial thromboplastin time (APTT) assays","volume":"48","author":"Barion","year":"2026","journal-title":"Int. J. Lab. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109771_bb0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00062752-199704050-00008","article-title":"Mechanisms of activity of lupus anticoagulants","volume":"4","author":"Rao","year":"1997","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.thromres.2026.109771_bb0120","article-title":"Performance of 6 routine coagulation assays on the new Roche Cobas t711 analyzer","volume":"17","author":"Oostendorp","year":"2019","journal-title":"Pract. Lab. Med."},{"issue":"1","key":"10.1016\/j.thromres.2026.109771_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH14-04-0361","article-title":"Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban","volume":"113","author":"Gosselin","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2026.109771_bb0130","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/jth.12720","article-title":"Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents","volume":"12","author":"Dale","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109771_bb0135","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.thromres.2012.09.004","article-title":"Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature","volume":"130","author":"Douxfils","year":"2012","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2026.109771_bb0140","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1160\/TH09-03-0176","article-title":"Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor","volume":"103","author":"Samama","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109771_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1538-7836.2010.04098.x","article-title":"Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays","volume":"9","author":"Hillarp","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109771_bb0150","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12913-020-5058-1","article-title":"Trends in anticoagulant prescribing: a review of local policies in English primary care","volume":"20","author":"Ho","year":"2020","journal-title":"BMC Health Serv. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109771_bb0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11239-016-1417-5","article-title":"Evaluation of anticoagulation selection for acute venous thromboembolism","volume":"43","author":"Badreldin","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"issue":"5","key":"10.1016\/j.thromres.2026.109771_bb0160","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1160\/TH11-11-0804","article-title":"Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate","volume":"107","author":"Douxfils","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109771_bb0165","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/jth.14784","article-title":"Laboratory testing in hemophilia: impact of factor and non-factor replacement therapy on coagulation assays","volume":"18","author":"Peyvandi","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"S 01","key":"10.1016\/j.thromres.2026.109771_bb0170","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1055\/a-1282-2251","article-title":"Extended half-life factor VIII\/factor IX products: assay discrepancies and implications for hemophilia management","volume":"40","author":"M\u00fcller","year":"2020","journal-title":"Hamostaseologie"},{"issue":"4","key":"10.1016\/j.thromres.2026.109771_bb0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/a-1665-6232","article-title":"An update on laboratory diagnostics in haemophilia A and B","volume":"42","author":"M\u00fcller","year":"2022","journal-title":"Hamostaseologie"},{"issue":"4","key":"10.1016\/j.thromres.2026.109771_bb0180","first-page":"250","article-title":"Gevoeligheid van verschillende APTT-reagentia","volume":"33","author":"Stroobants","year":"2008","journal-title":"Ned Tijdschr Klin Chem Labgeneesk."},{"issue":"7","key":"10.1016\/j.thromres.2026.109771_bb0185","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/imj.70103","article-title":"2025 guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri-operative and bleeding management","volume":"55","author":"Tran","year":"2025","journal-title":"Intern. Med. J."},{"issue":"3","key":"10.1016\/j.thromres.2026.109771_bb0190","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.thromres.2015.06.037","article-title":"Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INR","volume":"136","author":"Biedermann","year":"2015","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2026.109771_bb0195","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jtha.2023.12.013","volume":"22","author":"van den Besselaar","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2026.109771_bb0200","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1515\/cclm-2012-0055","article-title":"Measuring Rivaroxaban in a clinical laboratory setting, using common coagulation assays, Xa inhibition and thrombin generation","volume":"50","author":"Molenaar","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"issue":"9","key":"10.1016\/j.thromres.2026.109771_bb0205","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jth.12649","article-title":"Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays","volume":"12","author":"Hillarp","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109771_bb0210","first-page":"283","article-title":"Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide","volume":"110","author":"Douxfils","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109771_bb0215","first-page":"240","article-title":"Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study","volume":"111","author":"Gouin-Thibault","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109771_bb0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1309\/AJCPQ2NJD3PXFTUG","article-title":"Laboratory measurements of the oral direct factor Xa inhibitor edoxaban: comparison of prothrombin time, activated partial thromboplastin time, and thrombin generation assay","volume":"143","author":"Morishima","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"7\u20138","key":"10.1016\/j.thromres.2026.109771_bb0225","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/00365513.2018.1522664","article-title":"Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays","volume":"78","author":"Hillarp","year":"2018","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"2","key":"10.1016\/j.thromres.2026.109771_bb0230","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1160\/TH10-06-0342","article-title":"Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays","volume":"105","author":"Lindahl","year":"2011","journal-title":"Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:43:45Z","timestamp":1784133825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826001908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["S0049384826001908"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109771","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-analytical storage and reagent-dependent sensitivity as sources of variability in prothrombin time and activated partial thromboplastin time measurements","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Radboudumc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109771"}}